Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2013, Cilt: 30 Sayı: 2, 207 - 208, 31.07.2013
https://doi.org/10.5835/jecm.omu.30.02.027

Öz

Kaynakça

  • Atakli, D., Sözüer, D., Atay, T., Baybas, S., Arpaci, B., 1998. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 7, 63-66. Auvin, S., 2008. Treatment of juvenile myoclonic epilepsy. CNS Neurosci. Ther. 14, 227-233.
  • Bodenstein-Sachar, H., Gandelman-Marton, R., Ben-Zeev, B., Chapman, J., Blatt, I., 2011. Outcome of LTG treatment in juvenile myoclonic epilepsy. Acta Neurol. Scand. 124, 22-27.
  • Crespel, A., Genton, P., Berramdane, M., Coubes, P., Monicard, C., Baldy-Moulinier M., Gelisse, P., 2005. LTG associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 65, 762-764.
  • Duncan, S., 2007. Teratogenesis of sodium VPA. Curr. Opin. Neurol. 20, 175-180.
  • Janszky, J., Rásonyi, G., Halász, P., Olajos, S., Perenyi, J., 2000. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol. 23, 86-89.
  • Mantoan, L., Walker, M., 2011. Treatment options in juvenile myoclonic epilepsy. Curr. Treat. Options Neurol. 13, 355-370.
  • Mehndiratta, M.M., Aggarwal, P., 2002. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure. 11, 431-436.

Lamotrigine induced seizures in juvenile myoclonic epilepsy

Yıl 2013, Cilt: 30 Sayı: 2, 207 - 208, 31.07.2013
https://doi.org/10.5835/jecm.omu.30.02.027

Öz

Juvenile myoclonic epilepsy (JME) is a common epileptic syndrome. Before the development of the new antiepileptic drugs (AEDs) after the 1990s, Valproate (VPA) was the first-line treatment in juvenile myoclonic epilepsy. However, the frequent adverse effects and the risk for teratogenicity have resulted in a search for alternative therapies especially in women. Lamotrigine (LTG), topiramate, and levetiracetam, have been used as monotherapy or adjunctive therapy for juvenile myoclonic epilepsy in small patient series. We report a case of a thirty one-years-old female suffered from severe aggravation in myoclonic and generalized tonic-clonic (GTC) seizures after decreasing the lose of VPA and initiating LTG.

Kaynakça

  • Atakli, D., Sözüer, D., Atay, T., Baybas, S., Arpaci, B., 1998. Misdiagnosis and treatment in juvenile myoclonic epilepsy. Seizure 7, 63-66. Auvin, S., 2008. Treatment of juvenile myoclonic epilepsy. CNS Neurosci. Ther. 14, 227-233.
  • Bodenstein-Sachar, H., Gandelman-Marton, R., Ben-Zeev, B., Chapman, J., Blatt, I., 2011. Outcome of LTG treatment in juvenile myoclonic epilepsy. Acta Neurol. Scand. 124, 22-27.
  • Crespel, A., Genton, P., Berramdane, M., Coubes, P., Monicard, C., Baldy-Moulinier M., Gelisse, P., 2005. LTG associated with exacerbation or de novo myoclonus in idiopathic generalized epilepsies. Neurology. 65, 762-764.
  • Duncan, S., 2007. Teratogenesis of sodium VPA. Curr. Opin. Neurol. 20, 175-180.
  • Janszky, J., Rásonyi, G., Halász, P., Olajos, S., Perenyi, J., 2000. Disabling erratic myoclonus during lamotrigine therapy with high serum level-report of two cases. Clin. Neuropharmacol. 23, 86-89.
  • Mantoan, L., Walker, M., 2011. Treatment options in juvenile myoclonic epilepsy. Curr. Treat. Options Neurol. 13, 355-370.
  • Mehndiratta, M.M., Aggarwal, P., 2002. Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India. Seizure. 11, 431-436.
Toplam 7 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Sağlık Kurumları Yönetimi
Bölüm Internal Medical Sciences
Yazarlar

Betül Acar Bu kişi benim

Ersel Dağ Bu kişi benim

Yakup Türkel Bu kişi benim

Yayımlanma Tarihi 31 Temmuz 2013
Gönderilme Tarihi 15 Nisan 2013
Yayımlandığı Sayı Yıl 2013 Cilt: 30 Sayı: 2

Kaynak Göster

APA Acar, B., Dağ, E., & Türkel, Y. (2013). Lamotrigine induced seizures in juvenile myoclonic epilepsy. Journal of Experimental and Clinical Medicine, 30(2), 207-208. https://doi.org/10.5835/jecm.omu.30.02.027
AMA Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. Temmuz 2013;30(2):207-208. doi:10.5835/jecm.omu.30.02.027
Chicago Acar, Betül, Ersel Dağ, ve Yakup Türkel. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine 30, sy. 2 (Temmuz 2013): 207-8. https://doi.org/10.5835/jecm.omu.30.02.027.
EndNote Acar B, Dağ E, Türkel Y (01 Temmuz 2013) Lamotrigine induced seizures in juvenile myoclonic epilepsy. Journal of Experimental and Clinical Medicine 30 2 207–208.
IEEE B. Acar, E. Dağ, ve Y. Türkel, “Lamotrigine induced seizures in juvenile myoclonic epilepsy”, J. Exp. Clin. Med., c. 30, sy. 2, ss. 207–208, 2013, doi: 10.5835/jecm.omu.30.02.027.
ISNAD Acar, Betül vd. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine 30/2 (Temmuz 2013), 207-208. https://doi.org/10.5835/jecm.omu.30.02.027.
JAMA Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30:207–208.
MLA Acar, Betül vd. “Lamotrigine Induced Seizures in Juvenile Myoclonic Epilepsy”. Journal of Experimental and Clinical Medicine, c. 30, sy. 2, 2013, ss. 207-8, doi:10.5835/jecm.omu.30.02.027.
Vancouver Acar B, Dağ E, Türkel Y. Lamotrigine induced seizures in juvenile myoclonic epilepsy. J. Exp. Clin. Med. 2013;30(2):207-8.